Literature DB >> 20424957

Oxidative stress and hypertension: current concepts.

Ana M Briones1, Rhian M Touyz.   

Abstract

Hypertension is a major contributor to the development of renal failure, cardiovascular disease, and stroke. These pathologies are associated with vascular functional and structural changes including endothelial dysfunction, altered contractility, and vascular remodeling. Central to these phenomena is oxidative stress. Factors that activate pro-oxidant enzymes, such as NADPH oxidase, remain poorly defined, but likely involve angiotensin II, mechanical stretch, and inflammatory cytokines. Reactive oxygen species influence vascular, renal, and cardiac function and structure by modulating cell growth, contraction/dilatation, and inflammatory responses via redox-dependent signaling pathways. Compelling data from molecular and cellular experiments, together with animal studies, implicate a role for oxidative stress in hypertension. However, the clinical evidence is still controversial. This review provides current insights on the mechanisms of the generation of reactive oxygen species and the vascular effects of oxidative stress and discusses the significance of oxidative damage in experimental and clinical hypertension.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20424957     DOI: 10.1007/s11906-010-0100-z

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  79 in total

Review 1.  The effects of superoxide dismutase on H2O2 formation.

Authors:  Stefan I Liochev; Irwin Fridovich
Journal:  Free Radic Biol Med       Date:  2007-02-28       Impact factor: 7.376

Review 2.  Oxidative stress in prehypertension: rationale for antioxidant clinical trials.

Authors:  Selvaraj Nambiar; Sathiyapriya Viswanathan; Bobby Zachariah; Nandeesha Hanumanthappa; Sridhar Gopalakrishna Magadi
Journal:  Angiology       Date:  2008-09-15       Impact factor: 3.619

Review 3.  Molecular and cellular mechanisms in vascular injury in hypertension: role of angiotensin II.

Authors:  Rhian M Touyz
Journal:  Curr Opin Nephrol Hypertens       Date:  2005-03       Impact factor: 2.894

Review 4.  Nox proteins in signal transduction.

Authors:  David I Brown; Kathy K Griendling
Journal:  Free Radic Biol Med       Date:  2009-07-21       Impact factor: 7.376

5.  Preliminary characterisation of the promoter of the human p22(phox) gene: identification of a new polymorphism associated with hypertension.

Authors:  María U Moreno; Gorka San José; Josune Orbe; José A Páramo; Oscar Beloqui; Javier Díez; Guillermo Zalba
Journal:  FEBS Lett       Date:  2003-05-08       Impact factor: 4.124

Review 6.  Nitric oxide and superoxide in inflammation and immune regulation.

Authors:  T J Guzik; R Korbut; T Adamek-Guzik
Journal:  J Physiol Pharmacol       Date:  2003-12       Impact factor: 3.011

Review 7.  eNOS, metabolic syndrome and cardiovascular disease.

Authors:  Paul L Huang
Journal:  Trends Endocrinol Metab       Date:  2009-07-31       Impact factor: 12.015

8.  Renal redox-sensitive signaling, but not blood pressure, is attenuated by Nox1 knockout in angiotensin II-dependent chronic hypertension.

Authors:  Alvaro Yogi; Chantal Mercure; Joshuah Touyz; Glaucia E Callera; Augusto C I Montezano; Anna B Aranha; Rita C Tostes; Timothy Reudelhuber; Rhian M Touyz
Journal:  Hypertension       Date:  2008-01-14       Impact factor: 10.190

9.  Renal proximal tubular reabsorption is reduced in adult spontaneously hypertensive rats: roles of superoxide and Na+/H+ exchanger 3.

Authors:  Carolina Panico; Zaiming Luo; Sara Damiano; Francesca Artigiano; Pritmohinder Gill; William J Welch
Journal:  Hypertension       Date:  2009-10-05       Impact factor: 10.190

10.  Relationships between nitric oxide-mediated endothelial function, eNOS coupling and blood pressure revealed by eNOS-GTP cyclohydrolase 1 double transgenic mice.

Authors:  D Adlam; J K Bendall; J P De Bono; N J Alp; J Khoo; T Nicoli; M Yokoyama; S Kawashima; K M Channon
Journal:  Exp Physiol       Date:  2006-09-28       Impact factor: 2.969

View more
  109 in total

1.  Interleukin 6 knockout prevents angiotensin II hypertension: role of renal vasoconstriction and janus kinase 2/signal transducer and activator of transcription 3 activation.

Authors:  Michael W Brands; Amy K L Banes-Berceli; Edward W Inscho; Hind Al-Azawi; Ashlyn J Allen; Hicham Labazi
Journal:  Hypertension       Date:  2010-10-04       Impact factor: 10.190

Review 2.  Beneficial and harmful effects of exercise in hypertensive patients: the role of oxidative stress.

Authors:  Milica Dekleva; Jelena Suzic Lazic; Aleksandra Arandjelovic; Sanja Mazic
Journal:  Hypertens Res       Date:  2016-07-21       Impact factor: 3.872

Review 3.  The Impact of Chromium Supplementation on Blood Pressure: A Systematic Review and Dose-Response Meta‑Analysis of Randomized‑Controlled Trials.

Authors:  Abolfazl Lari; Somaye Fatahi; Mohammad Hassan Sohouli; Farzad Shidfar
Journal:  High Blood Press Cardiovasc Prev       Date:  2021-06-03

4.  The C-terminal module IV of connective tissue growth factor, through EGFR/Nox1 signaling, activates the NF-κB pathway and proinflammatory factors in vascular smooth muscle cells.

Authors:  Raúl R Rodrigues-Diez; Ana Belen Garcia-Redondo; Macarena Orejudo; Raquel Rodrigues-Diez; Ana Maria Briones; Enrique Bosch-Panadero; Gyorgy Kery; Janos Pato; Alberto Ortiz; Mercedes Salaices; Jesus Egido; Marta Ruiz-Ortega
Journal:  Antioxid Redox Signal       Date:  2015-01-01       Impact factor: 8.401

5.  Oxidative stress-mediated effects of angiotensin II in the cardiovascular system.

Authors:  Hairuo Wen; Judith K Gwathmey; Lai-Hua Xie
Journal:  World J Hypertens       Date:  2012-08-23

6.  Fenofibrate attenuates impaired ischemic preconditioning-mediated cardioprotection in the fructose-fed hypertriglyceridemic rat heart.

Authors:  Lalita Babbar; Nanjaian Mahadevan; Pitchai Balakumar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-01-17       Impact factor: 3.000

7.  Leukocyte-dependent responses of the microvasculature to chronic angiotensin II exposure.

Authors:  Alper Yildirim; Janice Russell; Li-Sue S Yan; Elena Y Senchenkova; D Neil Granger
Journal:  Hypertension       Date:  2012-10-22       Impact factor: 10.190

8.  The renoprotective effect of L-carnitine in hypertensive rats is mediated by modulation of oxidative stress-related gene expression.

Authors:  Sonia Zambrano; Antonio Jesús Blanca; María Victoria Ruiz-Armenta; José Luis Miguel-Carrasco; Elisa Revilla; Consuelo Santa-María; Alfonso Mate; Carmen María Vázquez
Journal:  Eur J Nutr       Date:  2012-12-06       Impact factor: 5.614

9.  D5 dopamine receptor decreases NADPH oxidase, reactive oxygen species and blood pressure via heme oxygenase-1.

Authors:  Quansheng Lu; Yu Yang; Van Anthony Villar; Laureano Asico; John E Jones; Peiying Yu; Hewang Li; Edward J Weinman; Gilbert M Eisner; Pedro A Jose
Journal:  Hypertens Res       Date:  2013-02-21       Impact factor: 3.872

10.  Angiotensin II induces DNA damage via AT1 receptor and NADPH oxidase isoform Nox4.

Authors:  Gholamreza Fazeli; Helga Stopper; Reinhard Schinzel; Chih-Wen Ni; Hanjoong Jo; Nicole Schupp
Journal:  Mutagenesis       Date:  2012-07-27       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.